Market Tracker

05/29 6:02pm ET

Alimera Sciences Inc (NASDAQ:ALIM)

4.23
Delayed Data
As of May 29
 -0.11 / -2.53%
Today’s Change
3.98
Today|||52-Week Range
6.54
-23.65%
Year-to-Date
No recent news for Alimera Sciences Inc.

Today’s Trading

Previous close4.34
Today’s open4.30
Day’s range4.11 - 4.33
Volume106,488
Average volume (3 months)146,335
Market cap$192.7M
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+43.83%
Earnings growth (this year)+17.95%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+349.95%
P/E ratioNM
Price/Sales26.57
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ANTHAnthera Pharmaceutic...+0.16+2.95%
NAVBNavidea Biopharmaceu...-0.04-3.10%
XENEXenon Pharmaceutical...+0.65+4.94%
MDGNMedgenics Inc+0.43+6.04%
Data as of 4:05pm ET, 05/29/2015

Financials

Next reporting dateAugust 6, 2015
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$8.4M
Annual profit (last year)-$36.7M
Net profit margin-435.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Charles Daniel Myers
Secretary, Chief Operating &
Financial Officer
Richard S. Eiswirth
Corporate headquarters
Alpharetta, Georgia

Forecasts